213 related articles for article (PubMed ID: 35689249)
1. Prognostic value of p16, p53, and pcna in sarcoma and an evaluation of immune infiltration.
Cai D; Ma X; Guo H; Zhang H; Bian A; Yu H; Cheng W
J Orthop Surg Res; 2022 Jun; 17(1):305. PubMed ID: 35689249
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of expression, prognostic significance and immune infiltration of RFC family genes in human sarcoma.
Wu G; Zhou J; Zhu X; Tang X; Liu J; Zhou Q; Chen Z; Liu T; Wang W; Xiao X; Wu T
Aging (Albany NY); 2022 Apr; 14(8):3705-3719. PubMed ID: 35483337
[TBL] [Abstract][Full Text] [Related]
3. Prognosis and Immune Infiltration of Chromobox Family Genes in Sarcoma.
Zhou J; Chen Z; Zou M; Wan R; Wu T; Luo Y; Wu G; Wang W; Liu T
Front Oncol; 2021; 11():657595. PubMed ID: 34046352
[TBL] [Abstract][Full Text] [Related]
4. Combined analysis of expression, prognosis and immune infiltration of GINS family genes in human sarcoma.
Zhang K; Zhou J; Wu T; Tian Q; Liu T; Wang W; Zhong H; Chen Z; Xiao X; Wu G
Aging (Albany NY); 2022 Jul; 14(14):5895-5907. PubMed ID: 35896011
[TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
[TBL] [Abstract][Full Text] [Related]
6. Association of NCAP family genes with prognosis and immune infiltration of human sarcoma.
Jiang G; Tian Q; Shi P; Li Z; Li Y; Chen J; Wang W; Chen R; Zhong H; Wu G
Aging (Albany NY); 2023 May; 15(10):4108-4121. PubMed ID: 37192046
[TBL] [Abstract][Full Text] [Related]
7. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of proliferating cell nuclear antigen (PCNA), AgNORs and P53 in non-Hodgkin's lymphomas.
Korkolopoulou P; Angelopoulou MK; Kontopidou F; Tsengas A; Patsouris E; Kittas C; Pangalis GA
Leuk Lymphoma; 1998 Aug; 30(5-6):625-36. PubMed ID: 9711925
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and Ki-67 in gastric cancer.
Setälä L; Kosma VM; Lipponen P; Naukkarinen A; Nordling S; Hollmén S; Eskelinen M; Syrjänen K; Alhava E
J Cancer Res Clin Oncol; 1998; 124(9):497-502. PubMed ID: 9808424
[TBL] [Abstract][Full Text] [Related]
10. Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas.
Montero E; Abreu C; Tonino P
J Cancer Res Clin Oncol; 2008 Feb; 134(2):193-201. PubMed ID: 17636327
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
[TBL] [Abstract][Full Text] [Related]
13. Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma.
Kim K; Kim DH; Chae SW; Shin JH; Kim HJ; Do SI; Lee HJ; Koo JH; Pyo JS; Sohn JH
Pathol Oncol Res; 2014 Apr; 20(2):409-15. PubMed ID: 24178677
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer.
Morawski K; Gabriel A; Namyslowski G; Ziólkowski A; Pietrawska V; Steplewska K
Eur Arch Otorhinolaryngol; 1999; 256(8):378-83. PubMed ID: 10525938
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
[TBL] [Abstract][Full Text] [Related]
16. [Association of the expression of p53 and p16INK4A with the clinical and morphological characteristicsof patients with head and neck squamous cell cancer].
Stukan AI; Chukhray OY; Porkhanov VA; Bodnya VN
Arkh Patol; 2019; 81(3):12-18. PubMed ID: 31317926
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of expression and prognosis for LMNB family genes in human sarcoma.
Wu G; Tian Q; Liu J; Zhou Q; Zou D; Chen Z; Wu T; Wang W; Xia H; Zhou J
Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356902
[TBL] [Abstract][Full Text] [Related]
18. YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p53.
Liao Q; Xiong J
Exp Ther Med; 2024 Jun; 27(6):255. PubMed ID: 38682111
[TBL] [Abstract][Full Text] [Related]
19. PCNA and p53 in urinary bladder cancer: correlation with histological findings and prognosis.
Inagaki T; Ebisuno S; Uekado Y; Hirano A; Hiroi A; Shinka T; Ohkawa T
Int J Urol; 1997 Mar; 4(2):172-7. PubMed ID: 9179692
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.
Hu TH; Wang CC; Huang CC; Chen CL; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Tai MH
Oncol Rep; 2007 Dec; 18(6):1417-26. PubMed ID: 17982625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
